Parkinson’s Disease Psychosis Clinical Trial
• Now Open in Savannah, GA
More than half of people with Parkinson’s disease have psychosis at some time. Psychosis also affects up to 75% of people with Parkinson’s disease dementia, and symptoms can include hallucinations and delusions. Learn more about a research study for an investigational medication for people with Parkinson’s disease and symptoms of psychosis.
Eligible participants…
- Must be age 40 or older
- Must be diagnosed with Parkinson’s disease
- Must have delusions (false or mistaken beliefs) and/or hallucinations (seeing or hearing things that are not really there)
- Must have a relative, housemate, or friend assist during the study and attend clinic visits
- May receive compensation for time and travel
- Do not need insurance to join this study
To learn more, watch this video: https://acp103063.longboat.com/
For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for you.
You can also talk to a Meridian enrollment specialist about this study by calling (912) 354-7676.
Study Location
Meridian Clinical Research
6602 Waters Avenue, Building C
Savannah, GA 31406
Sign up for more information...
About Meridian Clinical Research
Founded in 1999, Meridian studies the safety and effectiveness of new medicines, devices, and treatments. Its mission is to enrich lives by providing quality, compassionate care to patients and unparalleled clinical research services.
Clinical studies help scientists develop life-changing medicines, but it starts with you — participation makes it all possible. For almost 20 years, thousands of patients have trusted Meridian because of our focus on creating a positive patient experience.
© 2018 MERIDIAN CLINICAL RESEARCH | Privacy Policy